Glenmede Trust’s Innoviva INVA Stock Holding History

Glenmede Trust’s Portfolio INVA Stock Details INVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$339K	Sell	14,560 -2,351	-14%	-$50.6K	﹤0.01%	1106
2025 Q4	$338K	Buy	+16,911	New	+$330K	﹤0.01%	1091
2025 Q1	$355K	Buy	+19,562	New	+$351K	﹤0.01%	1020
2020 Q4	–	Sell	-1,328	Closed	-$13K	–	1715
2020 Q3	$13K	Buy	1,328 +108	+9%	+$1.37K	﹤0.01%	1776
2020 Q2	$17K	Buy	1,220 +381	+45%	+$5.18K	﹤0.01%	1650
2020 Q1	$11K	Hold	839	–	–	﹤0.01%	2389
2019 Q4	$11K	Buy	839 +436	+108%	+$5.35K	﹤0.01%	2389
2019 Q3	$4	Buy	403 +127	+46%	+$1.52K	﹤0.01%	2705
2019 Q2	$4	Hold	276	–	–	﹤0.01%	2689
2019 Q1	$3	Sell	276 -1,370	-83%	-$22.2K	﹤0.01%	2746
2018 Q4	$27	Buy	+1,646	New	+$26.7K	﹤0.01%	1853

Other funds holding INVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Glenmede Trust's INVA Position: Q1 2026 in Review

Glenmede Trust reduced its Innoviva (INVA) stake by 14% in Q1 2026, selling an estimated $50.6K and leaving 14,560 shares worth $339K. The position accounts for ﹤0.01% of the portfolio, ranked #1106.

Glenmede Trust first reported a position in INVA in Q4 2018 and has held it in 11 quarters since. The position peaked at $355K in Q1 2025. 286 funds tracked by Wall St. Rank hold INVA as of Q1 2026.

Glenmede Trust held 14,560 shares of Innoviva worth $339K as of Q1 2026.
Glenmede Trust sold 2,351 Innoviva shares in Q1 2026, an estimated $50.6K.
Innoviva made up ﹤0.01% of Glenmede Trust's portfolio in Q1 2026, its #1106 holding.
Glenmede Trust first reported a position in Innoviva in Q4 2018 and has held it in 11 quarters since.
Glenmede Trust's Innoviva position peaked at $355K in Q1 2025.
286 funds tracked by Wall St. Rank held Innoviva as of Q1 2026.

Based on Glenmede Trust's 13F filing for Q1 2026, filed 26 May 2026.